The prospective study aim to develop a multimodal deep learning model that integrates ultrasound images and cytological whole-slide images for more accurate malignant risk prediction of Bethesda III thyroid nodules.
(a) Patients who underwent fine-needle aspiration of thyroid nodules and received a cytological diagnosis of Bethesda Ⅲ.
(b) Patients who subsequently underwent thyroid surgery with a definitive histopathological diagnosis of benign or malignant lesions,.
(c) Availability of at least one ultrasound image acquired prior to surgery.
(a) Patients without confirmation by surgical pathology,.
(b) Patients without any available or usable ultrasound images.
Patients with a Bethesda Ⅲ thyroid nodule
Cohort
Prospective
Histopathology or cytopathology.
Other interventionThis is a observation stufy.
Pathological diagnosis.
WHO guidelines.
Click on the lead sponsor to view all of their trials.
